» Articles » PMID: 23692589

Polymorphism in the Interleukin-7 Receptor-alpha and Outcome After Allogeneic Hematopoietic Cell Transplantation with Matched Unrelated Donor

Overview
Journal Scand J Immunol
Date 2013 May 23
PMID 23692589
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-7 (IL-7) is essential for T cell development in the thymus and maintenance of peripheral T cells. The α-chain of the IL-7R is polymorphic with the existence of SNPs that give rise to non-synonymous amino acid substitutions. We previously found an association between donor genotypes and increased treatment-related mortality (TRM) (rs1494555G) and acute graft versus host disease (aGvHD) (rs1494555G and rs1494558T) after hematopoietic cell transplantation (HCT). Some studies have confirmed an association between rs6897932C and multiple sclerosis. In this study, we evaluated the prognostic significance of IL-7Rα SNP genotypes in 590-recipient/donor pairs that received HLA-matched unrelated donor HCT for haematological malignancies. Consistent with the primary studies, the rs1494555GG and rs1494558TT genotypes of the donor were associated with aGvHD and chronic GvHD in the univariate analysis. The Tallele of rs6897932 was suggestive of an association with increased frequency of relapse by univariate analysis (P = 0.017) and multivariate analysis (P = 0.015). In conclusion, this study provides further evidence of a role of the IL-7 pathway and IL-7Rα SNPs in HCT.

Citing Articles

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.

Barros P, Berthoud T, Aloufi N, Angel J Immunotargets Ther. 2021; 10:47-62.

PMID: 33728276 PMC: 7954429. DOI: 10.2147/ITT.S264149.


Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.

Partanen J, Hyvarinen K, Bickeboller H, Bogunia-Kubik K, Crossland R, Ivanova M Front Immunol. 2020; 11:575492.

PMID: 33193367 PMC: 7604383. DOI: 10.3389/fimmu.2020.575492.


IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?.

Lundtoft C, Seyfarth J, Jacobsen M Genes Immun. 2020; 21(2):83-90.

PMID: 31929513 DOI: 10.1038/s41435-019-0091-y.


Deleterious and Oncogenic Mutations in the .

Campos L, Pissinato L, Yunes J Cancers (Basel). 2019; 11(12).

PMID: 31817502 PMC: 6966522. DOI: 10.3390/cancers11121952.


IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status.

Ceausu A, Rodriguez-Gallego E, Peraire J, Lopez-Dupla M, Domingo P, Vilades C Sci Rep. 2019; 9(1):15722.

PMID: 31673011 PMC: 6823538. DOI: 10.1038/s41598-019-52025-8.


References
1.
Teutsch S, Booth D, Bennetts B, Heard R, Stewart G . Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur J Hum Genet. 2003; 11(7):509-15. DOI: 10.1038/sj.ejhg.5200994. View

2.
Hoe E, McKay F, Schibeci S, Gandhi K, Heard R, Stewart G . Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. J Immunol. 2010; 184(5):2512-7. DOI: 10.4049/jimmunol.0902900. View

3.
Hoffmann P, Edinger M . CD4+CD25+ regulatory T cells and graft-versus-host disease. Semin Hematol. 2006; 43(1):62-9. DOI: 10.1053/j.seminhematol.2005.09.006. View

4.
Thiant S, Yakoub-Agha I, Magro L, Trauet J, Coiteux V, Jouet J . Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse. Bone Marrow Transplant. 2010; 45(10):1546-52. DOI: 10.1038/bmt.2010.13. View

5.
Goodwin R, Friend D, Ziegler S, Jerzy R, Falk B, Gimpel S . Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell. 1990; 60(6):941-51. DOI: 10.1016/0092-8674(90)90342-c. View